Patent Foramen Ovale Closure Procedure

  • Arwin Saleh Mangkuanom Member
  • Doni Firman Departement of Cardiology and Vascular Medicine, Universitas Indonesia / National Cardiovascular Center Harapan Kita, Jakarta – Indonesia.
Keywords: -


Patent foramen ovale is strongly associated with cryptogenic stroke. Various
clinical trials has shown the association between cryptogenic stroke and
incidence of undelrying patent foramen ovale, these trials also shown the
decrease of cryptogenic stroke incidence with the treatment of patent
foramen ovale Lesion. In the absence of absolute contraindications, patients
with patent foramen ovale are advised to undergo closure. Preprocedural
examinations such as trans esophageal echocardiography and pretreatment
with anticoagulants are required to prevent peri and postprocedural adverse
events. Currently, patent foramen ovale Closure can be done through a
percutaneous access with minimal risk. Treatment of patent foramen ovale
can help decrease future incidences of strokes


Download data is not yet available.


1. Alsheikh-Ali, A. A., Thaler, D. E. & Kent, D. M. Patent foramen ovale in cryptogenic stroke: Incidental or pathogenic? Stroke (2009) doi:10.1161/STROKEAHA.109.547828.
2. Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia. in Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia (ed. Mojadidi M Khalid, Tobis Jonathan M, M. B.) 217–219 (Elsevier Inc., 2020). doi:
3. Bridges, N. D. et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) doi:10.1161/01.cir.86.6.1902.
4. Carroll, J. D. et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N. Engl. J. Med. (2013) doi:10.1056/NEJMoa1301440.
5. Saver, J. L. et al. Longterm outcomes of patent foramen ovale closure or medical therapy after stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1610057.
6. Mas, J. L. et al. Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1705915.
7. Lee, P. H. et al. Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial. J. Am. Coll. Cardiol. (2018) doi:10.1016/j.jacc.2018.02.046.
8. Søndergaard, L. et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N. Engl. J. Med. (2017) doi:10.1056/NEJMoa1707404.
9. Morais, L. A. et al. Rope score as a predictor of recurrent ischemic events after percutaneous patent foramen ovale closure. Int. Heart J. (2018) doi:10.1536/ihj.17-489.
10. Garg, A. et al. Recurrent Stroke Reduction with Patent Foramen Ovale Closure versus Medical Therapy Based on Patent Foramen Ovale Characteristics: A Meta-Analysis of Randomized Controlled Trials. Cardiol. (2019) doi:10.1159/000500501.
11. Giblett, J. P., Abdul-Samad, O., Shapiro, L. M., Rana, B. S. & Calvert, P. A. Patent foramen ovale closure in 2019. Interv. Cardiol. Rev. (2019) doi:10.15420/icr.2018.33.2.
12. Vaduganathan, M. et al. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials. Am. J. Med. (2018) doi:10.1016/j.amjmed.2017.11.027.
13. Mojadidi, M. K. et al. Cryptogenic Stroke and Patent Foramen Ovale. Journal of the American College of Cardiology (2018) doi:10.1016/j.jacc.2017.12.059.
14. Merkler, A. E. et al. Safety outcomes after percutaneous transcatheter closure of patent foramen ovale. Stroke (2017) doi:10.1161/STROKEAHA.117.018501.
15. Horlick, E. et al. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter. Cardiovasc. Interv. (2019) doi:10.1002/ccd.28111.
Views & Downloads
Abstract views: 782   
PDF downloads: 644   
How to Cite
Mangkuanom, A., & Firman, D. (2021). Patent Foramen Ovale Closure Procedure. Indonesian Journal of Cardiology, 42(3).